<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Hainan-Boao-Lecheng on Bioecon</title><link>https://en.bioecon.ru/companies/hainan-boao-lecheng/</link><description>Recent content in Hainan-Boao-Lecheng on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sun, 05 Jul 2026 11:11:43 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/hainan-boao-lecheng/index.xml" rel="self" type="application/rss+xml"/><item><title>Regulatory sandboxes for biotech</title><link>https://en.bioecon.ru/technology/regulatory-sandboxes-biotech/</link><pubDate>Sun, 05 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/regulatory-sandboxes-biotech/</guid><description>Time- and space-bounded regulatory regimes that let biotech companies test breakthrough innovations — cultivated meat, unregistered cell therapies, novel-food bioprocesses — under direct regulator supervision before standard registration, cutting years off a 10-12-year approval timeline.</description></item></channel></rss>